close

Freebase is currently in read-only mode

Topic

Created by fda_medical_bot on 1/7/2012

Rasburicase 1.5 kit ^en

mid: /m/0hqv21t notable type: /medicine/drug_formulation notable for: /medicine/drug_formulation

Rasburicase kit, for intravenous administration, consisting of: 1.5mg/mL rasburicase.Indications:Elitek is a recombinant urate-oxidase indicated for initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid (1). Limitation of use: Elitek is indicated only for a single course of treatment (1). [ - ]

Add type

Metaweb System Types

Object

Common

Topic

Medicine

Drug formulation

Freebase

Object profile

Object is not asserted on this topic.

ID /type/object/id

-

GUID /type/object/guid

#9202a8c04000641f800000001f6d0839

Type /type/object/type

Drug formulation
Topic

Name /type/object/name

- - Edit
  - Delete
Rasburicase 1.5 kit

Key /type/object/key

- - Edit
  - Delete
/base/medicaldrugs/fda_load/form_08GY9K1EUO_1_5mg_mL_kit_intravenous

Timestamp /type/object/timestamp

Saturday, January 07, 2012 8:47 AM

Permission /type/object/permission

/boot/all_permission

Creator /type/object/creator

fda_medical_bot

Attribution /type/object/attribution

fda_medical_bot

Search /type/object/search

-

Machine ID /type/object/mid

/m/0hqv21t

Also known as /common/topic/alias

-

Description /common/topic/description

- - Edit
  - Delete
Rasburicase kit, for intravenous administration, consisting of: 1.5mg/mL rasburicase.Indications:Elitek is a recombinant urate-oxidase indicated for initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid (1). Limitation of use: Elitek is indicated only for a single course of treatment (1).

Image /common/topic/image

-

Official website /common/topic/official_website

-

Topic equivalent webpage /common/topic/topic_equivalent_webpage

-

Social media presence /common/topic/social_media_presence

-

Topical webpage /common/topic/topical_webpage

-

Subjects /common/topic/subjects

-

Subject of /common/topic/subject_of

-

Web Link(s) (deprecated) /common/topic/webpage

-

Properties /common/topic/properties

-

Article /common/topic/article

<p>Rasburicase kit, for intravenous administration, consisting of: 1.5mg/mL rasburicase.</p><p>In...

Weblink /common/topic/weblink

-

Notable for /common/topic/notable_for

Drug formulation

Notable types /common/topic/notable_types

Drug formulation

Active ingredients /medicine/drug_formulation/active_ingredients

Rasburicase

Strength /medicine/drug_formulation/strength

Strength value	Strength units	Active ingredient	Drug formulations available in this strength
Edit Delete View CVT 1.5	mg/mL	Rasburicase	-

Dosage form /medicine/drug_formulation/dosage_form

Drug Kit

Routes of administration /medicine/drug_formulation/routes

Intravenous

Brand names /medicine/drug_formulation/brand_names

- - Edit
  - Delete
Elitek

Drug category /medicine/drug_formulation/drug_category

Biologic

Formulation of /medicine/drug_formulation/formulation_of

Rasburicase

Active ingredient moieties /medicine/drug_formulation/active_ingredient_moieties

Rasburicase

Active moieties (deprecated) /medicine/drug_formulation/active_moieties

-

Pregnancy category /medicine/drug_formulation/pregnancy_category

-

Legal status /medicine/drug_formulation/legal_status

Prescription drug

Manufactured forms /medicine/drug_formulation/manufactured_forms

Reference form /medicine/drug_formulation/reference_form

-

Object profile is not asserted on this topic. Assert type now.

Object generation time /freebase/object_profile/object_generation_time

- - Edit
  - Delete
Friday, May 24, 2013 9:28 AM

Link count /freebase/object_profile/link_count

-

Comments

Hide